GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » 5-Year Yield-on-Cost %

Artgen Biotech PJSC (MIC:ABIO) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC 5-Year Yield-on-Cost %?

Artgen Biotech PJSC's yield on cost for the quarter that ended in Jun. 2023 was 0.00.


The historical rank and industry rank for Artgen Biotech PJSC's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Artgen Biotech PJSC's highest Yield on Cost was 2.78. The lowest was 1.24. And the median was 1.67.


MIC:ABIO's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.89
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Artgen Biotech PJSC's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Artgen Biotech PJSC's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artgen Biotech PJSC's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's 5-Year Yield-on-Cost % falls into.



Artgen Biotech PJSC 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Artgen Biotech PJSC is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Artgen Biotech PJSC  (MIC:ABIO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Artgen Biotech PJSC 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Artgen Biotech PJSC (MIC:ABIO) Business Description

Traded in Other Exchanges
N/A
Address
Prospect of the 60th Anniversary, Moscow, RUS, 117036
Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.